95 related articles for article (PubMed ID: 2529439)
41. The hepatitis B vaccine.
Kynes PM
J Enterostomal Ther; 1985; 12(4):144-6. PubMed ID: 3848443
[No Abstract] [Full Text] [Related]
42. Erythema multiforme associated with hepatitis B vaccine.
Wakeel RA; White MI
Br J Dermatol; 1992 Jan; 126(1):94-5. PubMed ID: 1531612
[No Abstract] [Full Text] [Related]
43. Uveitis after hepatitis B vaccination.
Fried M; Conen D; Conzelmann M; Steinemann E
Lancet; 1987 Sep; 2(8559):631-2. PubMed ID: 2887922
[No Abstract] [Full Text] [Related]
44. Erythema nodosum following typhoid vaccination.
Thomson BJ; Nuki G
Scott Med J; 1985 Jul; 30(3):173. PubMed ID: 4059905
[TBL] [Abstract][Full Text] [Related]
45. Erythema nodosum and hepatitis B virus (HBV) infection.
Maggiore G; Grifeo S; Marzani MD
J Am Acad Dermatol; 1983 Oct; 9(4):602-3. PubMed ID: 6630624
[No Abstract] [Full Text] [Related]
46. [Erythema nodosum as a presentation form of hepatitis B and acute leukemia].
Ventura Valcárcel P; García Porrúa C
Rev Clin Esp (Barc); 2013 Mar; 213(2):124-5. PubMed ID: 23273972
[No Abstract] [Full Text] [Related]
47. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine.
Herroelen L; de Keyser J; Ebinger G
Lancet; 1991 Nov; 338(8776):1174-5. PubMed ID: 1682594
[TBL] [Abstract][Full Text] [Related]
48. [Erythema nodosum disclosing chronic active hepatitis C].
Gillet-Terver MN; Modiano P; Gogolewski S; Gaucher P; Schmutz JL
Presse Med; 1995 Sep; 24(26):1221. PubMed ID: 7567852
[No Abstract] [Full Text] [Related]
49. The risk of AIDS after hepatitis vaccination.
JAMA; 1985 May 24-31; 253(20):2960-1. PubMed ID: 3158754
[No Abstract] [Full Text] [Related]
50. Hepatitis B vaccination and AIDS.
Kato S; Iwasaki H; Kimura M; Togo Y
JAMA; 1985 Jul; 254(1):53. PubMed ID: 3158758
[No Abstract] [Full Text] [Related]
51. The safety of the hepatitis B vaccine.
Meric AL
JAMA; 1987 Jan; 257(3):315-6. PubMed ID: 2948031
[No Abstract] [Full Text] [Related]
52. A possible systemic reaction to hepatitis B vaccine.
Snider GB; Gogate SA
JAMA; 1985 Mar; 253(9):1260-1. PubMed ID: 3155811
[No Abstract] [Full Text] [Related]
53. Erythema nodosum and hepatitis C.
Domingo P; Ris J; Martinez E; Casas F
Lancet; 1990 Dec; 336(8727):1377. PubMed ID: 1978180
[No Abstract] [Full Text] [Related]
54. Yeast-derived hepatitis B vaccine and yeast sensitivity.
Brightman CA; Scadding GK; Dumbreck LA; Latchman Y; Brostoff J
Lancet; 1989 Apr; 1(8643):903. PubMed ID: 2564981
[No Abstract] [Full Text] [Related]
55. AIDS transmission by hepatitis b vaccine.
Vogel R
Br Dent J; 1985 Dec; 159(12):391. PubMed ID: 2935176
[No Abstract] [Full Text] [Related]
56. Exacerbation of eczema by formalin-containing hepatitis B vaccine in formaldehyde-allergic patient.
Ring J
Lancet; 1986 Aug; 2(8505):522-3. PubMed ID: 2875273
[No Abstract] [Full Text] [Related]
57. Inflammatory nodular reactions after hepatitis B vaccination due to aluminium sensitization.
Cosnes A; Flechet ML; Revuz J
Contact Dermatitis; 1990 Aug; 23(2):65-7. PubMed ID: 2145128
[TBL] [Abstract][Full Text] [Related]
58. Covid-19 vaccine associated erythema nodosum: Factors to consider.
Damevska K; Simeonovski V
Dermatol Ther; 2022 May; 35(5):e15410. PubMed ID: 35218272
[No Abstract] [Full Text] [Related]
59. [Case of A-B-O incompatibility].
URUETA FERRANS CA
Rev Colomb Pediatr Pueric; 1951 Oct; 11(1):21-4. PubMed ID: 14892412
[No Abstract] [Full Text] [Related]
60. Hepatitis B surface antigen testing.
Moraleda MH
Infect Control; 1985 Jun; 6(6):216-7. PubMed ID: 3848418
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
